Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
An ironic twist of fate.
The law of unintended consequences.
Most of you are overly invested in Acadia pharma.
Most of you are deep underwater with your investment.
Most of you have averaged down and even taken out a 2nd mortgage to do so.
Most of you are hoping that Trofinetide will be FDA approved for RETT syndrome on March 12th, 2023.
Most of you think Acadia's share price will rise upon FDA approval.
Most of you are just hoping to break even to bail out of this Titanic boat anchor.
Most of you don't realize that the stock price will dive upon Trofinetide approval.
It costs more to manufacture and sell Trofinetide, than full sales could ever pay for let alone make a profit.
The same is true of Nuplazid, it costs more to manufacture and sell, than any meager "profits" can bring in.
The Baker Brothers only own Acadia pharma stock, as a tax write-off...
Every hedge fund, needs one bad apple in the bunch, just to offset taxes on the other, profitable holdings.
Criss-Cross, you bet the wrong dog!
The volume today has been only the selling of shares, back into the public float/pool, no one is buying shares, hence the downward pressure on the stock price. It's simply not true that for every seller, there is a buyer, there are many shares still in the public float that Acadia owns, to sell into the market, for their own financial gain, when and if those shares are purchased. When a person buys a stock out of the public float pool, that money goes directly into Acadia's pockets...
OK, that's good but what about this?
https://www.lawow.org/karp-vs-acadia-pharmaceuticals-inc-2021-11-22/
2 people died because Acadia illegally hired a convicted felon as a pharma sales, rep that sold them fentanyl. Unlimited damages and liabilities. Why would Acadia hire a felon? Why does Stephen Davis have his shirt unbuttoned down so far during conference calls?
Uh Oh! what about this lawsuit??? Hmmm...????
NEW ORLEANS, Nov. 11, 2022 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into ACADIA Pharmaceuticals Inc. (NasdaqGS: ACAD).
On July 20, 2020, the Company announced that the FDA had accepted for filing its supplemental new drug application ("sNDA") for its drug candidate, pimavanserin, for the treatment of dementia-related psychosis ("DRP"). Thereafter, the company repeatedly stated the FDA had not identified any potential review issues and reiterated the drug's efficacy. Then, on April 5, 2021, the Company disclosed that the FDA had rejected the sNDA, citing a lack of statistical significance regarding some of the subgroups of dementia and inadequate numbers of patients with some less common dementia subtypes.
Wow, yet another lawsuit!
https://casetext.com/case/acadia-pharm-v-aurobindo-pharma
Uh oh, Acadia going out of business due to 2 wrongful death lawsuits, with unlimited damages.
https://www.lawow.org/karp-vs-acadia-pharmaceuticals-inc-2021-11-22/
OoooGAAAaaBoooGA!
You buy more KemPharm Inc., shares!
Remember when you said KMPH could be $20 in 12/2021 ?
Remember when you said "follow me" and make money??
If you're average is $9.89, how far underwater are you?
OoooGAAAaaBoooGA!
You buy more Onco Vista Innovative Therapies!
Uh oh doebop, it doesn't look good for KMPH. Lowers sales, highers costs, bigger losses.
What about the latest shelf offering and the lowered guidance? Do you enjoy it?
Big mistake listening to Harry Crumb! Keep in mind that he invested in a used car salesman owned scam with with water less tooth brushes and paper less toilet paper.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for NUPLAZID(R) (pimavanserin) for the treatment of hallucinations and delusions associated with Alzheimer's disease psychosis (ADP).
The CRL indicated that the FDA has completed review of the application, determining that it could not approve the sNDA in its present form, and recommended that Acadia conduct an additional trial in ADP. While the FDA stated that Study 019 demonstrated a statistically significant treatment effect on its primary endpoint, they concluded that there are limitations in the interpretability of the 019 results. The FDA also stated that the positive treatment effect of pimavanserin on dementia-related psychosis in Study 045 (HARMONY) appeared to be driven by the robustly positive results in the Parkinson's disease dementia subgroup, a condition they stated is subsumed within the currently approved NUPLAZID Parkinson's disease psychosis (PDP) indication. Up to 50 percent of PDP patients have dementia.(1)
"We are disappointed with this outcome. The treatment of Alzheimer's disease psychosis continues to be an area of high unmet need, for which there is no approved therapy," said Steve Davis, Chief Executive Officer. "We want to express our gratitude to all of the patients, their families and investigators who have participated in our clinical trials."
NUPLAZID was approved in the U.S. in 2016 and is the first and only treatment for hallucinations and delusions associated with PDP.
Smell my shorts, shortie! In your face!
State of New Jersey Common Pension Fund D trimmed its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Rating) by 34.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 96,642 shares of the biopharmaceutical company’s stock after selling 50,023 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in ACADIA Pharmaceuticals were worth $2,341,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the stock. Lazard Asset Management LLC grew its position in shares of ACADIA Pharmaceuticals by 19.4% in the 4th quarter. Lazard Asset Management LLC now owns 3,115 shares of the biopharmaceutical company’s stock valued at $72,000 after buying an additional 506 shares during the last quarter. Personal CFO Solutions LLC grew its position in shares of ACADIA Pharmaceuticals by 6.7% in the 1st quarter. Personal CFO Solutions LLC now owns 15,846 shares of the biopharmaceutical company’s stock valued at $384,000 after buying an additional 1,000 shares during the last quarter. Kalos Management Inc. grew its position in shares of ACADIA Pharmaceuticals by 6.0% in the 4th quarter. Kalos Management Inc. now owns 19,689 shares of the biopharmaceutical company’s stock valued at $340,000 after buying an additional 1,114 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of ACADIA Pharmaceuticals by 8.0% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 17,927 shares of the biopharmaceutical company’s stock valued at $434,000 after buying an additional 1,334 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale grew its position in shares of ACADIA Pharmaceuticals by 2.7% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 68,700 shares of the biopharmaceutical company’s stock valued at $1,637,000 after buying an additional 1,800 shares during the last quarter. 91.74% of the stock is owned by hedge funds and other institutional investors.
I meant;
Are you experiencing diarrhea due to the stress?
Are you experiencing diarrhea do to the stress?
I figured it out. The only reason why the successful baker brothers have shares of Acadia is for tax right off purposes, to offset the huge profits from their other well managed pharmas.
Hey foo, I hope your shorting this!
I figured it out. The only reason why the successful baker brothers have shares of Acadia is for tax right off purposes, to offset the huge profits from their other well managed pharmas.
Yup, ya Nope, those shares are being sold at a total loss.
Wow, did you make the stock purchase all at once? After it went to $11, it dropped way, way back down, because of the terrible shelf offering of shares of stock.
Well, the late, great, BTB, otherwise know as Billy T Bone, used to like saying that the fair market value of POTN was .003 and he was totally right, except that the value now is even lower .0002 and investors who lost on this earned nothing back from the court case and corruption charges...
They are trying to change their name, to cover their illegal fraud tracks, to hide in plain site. Remember, used cars salesmen started this company and...remember the waterless toothbrush, not to mention the paperless toilet paper...
I agree, Trofinetide is a great, big and expensive joke as compared to A2-73 and thus far, I have lost 43% of my ACAD-EEEEEGAAAAADS! investment, so expecting to lose the other 57% on Thursday, August 4th 2022.
Steve Davis knew that submitting the sNDA a 2nd time for ADP, without any new information, without any additional data, without any changes and without explaining anything positive to the Adcom, that it would be rejected again and that it would crash the stock price, so that's why he sold so much stock recently. Perhaps after 8/4/22, he will buy shares back at $7 ? Only to fumble more and more later, with an opened-shirt and flabby belly hanging out during the conference call meetings.
Jefferies Financial Group cut shares of ACADIA Pharmaceuticals from a "buy" rating to an "underperform" rating and decreased their price objective for the company from $25.00 to $10.00 in a report on Tuesday, June 21st.
How much have you lost on Acadia? I mean thus far? How much more will you lose after the 8/4/22 PDFU date?
780 Shares @ $6.26.
Uh Oh! The Baker Brothers filed to sell 42,393,855 shares of common stock. Ask yourself, why would the Baker Brothers get out? Well, the must have realized that Acadia is a disaster and going downhill, sinking, much like the Titanic?
Ok, so no voting on the dilution, just make the dilution happen?
Uh oh, massive shelf offering!! Look out below!
https://ih.advfn.com/stock-market/NASDAQ/acadia-pharmaceuticals-ACAD/stock-news/88213793/automatic-shelf-registration-statement-of-securiti
Ok, so what you're saying is that with this mass dilution, it will lower the stock price even more, below the resistance level, so that even if the FDA approved Nuplazid for APD, that the stock price would still go lower, due to the massive and irresponsible dilution and that Acadia does not care in the slightest bit for their retail investors?
Wash, rinse, repeat. Changing the name, to lure in more unsuspecting victims.
As of 05/25/22
Support 15.16
Resistance 16.82
Stop loss 13.73
Now now, don't be negative. This is awesome!
No, I'm not paid for any posts. I have changed my negative ways! The curse has been lifted, by the blood of Jesus! Let's the blessings pour out upon us!!!
Restore what has been lost!
Make us Whole!
Amen!
Give me the link to the biotech values board or I will search for it!
Good points Ian and you're right! Rock n' Roll with Acadia pharma! Improving the lives of patients and improving the lives of confident investors!
A new revelation! Acadia will be successful very soon! Just hold on! This 2nd time around, Nuplazid will receive approval for ADP. The treatment for RETT syndrome will also be approved soon! Also, Nuplazid will be approve for Schizophrenia! We are going to win, for the benefit of the suffering patients and for our benefit as well! Rock n' Roll with Acadia! The Baker Brothers ROCK!!!